Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancer Preparing for initial clinical data disclosure for ACR-2316 from the Phase 1 trial ...

Q3 2025 Total Net Product Sales of $12.5 Million, 79% Year Over Year Growth ~ ~ Q3 2025 Positive Cash Flow from Operations, Cash Position Grew to $22 Million ~ ~ Japan Clinical Trial (STS-J01) ...

Students aren’t necessarily missing the math, they’re missing how to make sense of the problem itself. Once we see ...

Time bends in early parenthood. Days can feel endless, then years flash by. Here is why that happens, plus gentle ways to ...

Objective To investigate the occurrence of unintentional injuries among children aged 3 to 12 in China over the past 5 years, and to provide a scientific basis for the prevention and control of such ...

After struggling in the first half of 2025, municipal bonds delivered a solid third-quarter gain mainly due to strong ...